Nanoviricides (NNVC) Assets Average (2011 - 2026)

Nanoviricides has disclosed Assets Average across 16 years of filings, most recently posting $11.2 million for Q1 2026.

• In Q1 2026, Assets Average rose 4.09% year-over-year to $11.2 million; the TTM figure through Mar 2026 stood at $11.2 million (up 4.09% YoY), while the FY2025 annual figure was $10.8 million, down 27.17% from the prior year.
• Assets Average came in at $11.2 million for Q1 2026 at Nanoviricides, up from $10.3 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $26.0 million in Q1 2022 to a low of $8.6 million in Q3 2025.
• Average Assets Average over 5 years is $15.3 million, with a median of $12.4 million recorded in 2024.
• Year-over-year, Assets Average sank 36.09% in 2024 and gained 4.09% in 2026.
• Over 5 years, Assets Average stood at $21.2 million in 2022, then plunged by 32.06% to $14.4 million in 2023, then retreated by 19.11% to $11.7 million in 2024, then fell by 11.52% to $10.3 million in 2025, then advanced by 9.03% to $11.2 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $11.2 million in Q1 2026, $10.3 million in Q4 2025, and $8.6 million in Q3 2025.